1. Home
  2. FGEN vs ORKT Comparison

FGEN vs ORKT Comparison

Compare FGEN & ORKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • ORKT
  • Stock Information
  • Founded
  • FGEN 1993
  • ORKT 2003
  • Country
  • FGEN United States
  • ORKT Singapore
  • Employees
  • FGEN N/A
  • ORKT N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • ORKT
  • Sector
  • FGEN Health Care
  • ORKT
  • Exchange
  • FGEN Nasdaq
  • ORKT NYSE
  • Market Cap
  • FGEN 34.5M
  • ORKT 34.7M
  • IPO Year
  • FGEN 2014
  • ORKT 2024
  • Fundamental
  • Price
  • FGEN $0.52
  • ORKT $1.29
  • Analyst Decision
  • FGEN
  • ORKT Strong Buy
  • Analyst Count
  • FGEN 0
  • ORKT 1
  • Target Price
  • FGEN N/A
  • ORKT $5.00
  • AVG Volume (30 Days)
  • FGEN 709.3K
  • ORKT 7.9M
  • Earning Date
  • FGEN 02-24-2025
  • ORKT 10-16-2024
  • Dividend Yield
  • FGEN N/A
  • ORKT N/A
  • EPS Growth
  • FGEN N/A
  • ORKT N/A
  • EPS
  • FGEN N/A
  • ORKT N/A
  • Revenue
  • FGEN $180,015,000.00
  • ORKT $3,904,592.00
  • Revenue This Year
  • FGEN $21.91
  • ORKT N/A
  • Revenue Next Year
  • FGEN N/A
  • ORKT N/A
  • P/E Ratio
  • FGEN N/A
  • ORKT N/A
  • Revenue Growth
  • FGEN 16.15
  • ORKT N/A
  • 52 Week Low
  • FGEN $0.18
  • ORKT $0.62
  • 52 Week High
  • FGEN $2.80
  • ORKT $8.00
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 53.72
  • ORKT N/A
  • Support Level
  • FGEN $0.46
  • ORKT N/A
  • Resistance Level
  • FGEN $0.51
  • ORKT N/A
  • Average True Range (ATR)
  • FGEN 0.04
  • ORKT 0.00
  • MACD
  • FGEN -0.00
  • ORKT 0.00
  • Stochastic Oscillator
  • FGEN 78.67
  • ORKT 0.00

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.

About ORKT ORANGEKLOUD TECHNOLOGY INC

Orangekloud Technology Inc is a company that operates through its subsidiaries provide IT consultancy services and distribution of related products and services. The Company also offers ERPs predominately in Singapore. It derives revenue from platform subscriptions, license and products and professional services.

Share on Social Networks: